Esophageal Diseases  >>  TNFerade (golnerminogene pradenovec)  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
TNFerade (golnerminogene pradenovec) / Precigen
NCT00051480: Study of TNFerade™ Gene Therapy, Radiation, 5-FU and Cisplatin in Esophageal Cancer

Completed
2
US
TNFerade
GenVec
Esophageal Cancer
 
 

Download Options